On May 13th, F-Prime, alongside 5AM Ventures, Atlas Venture, Osage University Partners (OUP), and RA Capital Management hosted Science2Startup.

Scientists, investors, and industry leaders gathered at The Engine in Cambridge for a series of presentations from entrepreneurs advancing promising early-stage science.

Science2Startup is a forum for leading scientists from around the world to present their ideas and engage with investors and executives across the Boston biotechnology hub.

Science2Startup continues to be a platform for academic innovators to share company-forming ideas across biotech and life sciences. This year’s program covered a wide range of areas, including stem cell-derived therapies for diabetes, as well as new approaches to osteoporosis, AML, pulmonary hypertension, neurodegeneration, kidney disease, uterine fibroids, and the opioid epidemic.

It’s encouraging to see early-stage science continue to move toward real-world application.

To learn more, visit the S2S website with this link.